INTERCEPT Blood System for Platelets



Bacteria

The INTERCEPT Blood System for platelets has been shown to inactivate a variety of bacteria in platelet components. Inactivation studies using a range of gram positive and gram negative pathogenic bacteria demonstrated inactivation of approximately 6 logs of organisms, with the exception of P. aeruginosa and B. cereus (including spores), which showed reductions of 4.5 and 3.6 logs, respectively. Bacterial spores are resistant to inactivation; however, spore-forming bacteria in the vegetative state are sensitive to inactivation.
The results of these studies are summarized below:

Table 2: Inactivation Claims - Bacteria

Bacterial Species Tested Using the INTERCEPT Blood System
Extent of Inactivation*
(log10 reduction)
 Platelets in plasma/Additive Solution
Platelets in plasma
Gram-Negative Bacteria
Escherichia coli
>6.4
≥7.3
Serratia marcescens
>6.7
-
Klebsiella pneumoniae
>5.6
≥6.7
Pseudomonas aeruginosa
4.5
-
Salmonella choleraesuis
>6.2
-
Yersinia enterocolitica
>5.9
>7.3
Enterobacter cloacae
5.9
-
Anaplasma phagocytophilum (HGE agent)**
-
>4.2
Gram-Positive Bacteria 
Staphylococcus epidermidis
>6.6
>7.4
Staphylococcus aureus
6.6
>7.6
Streptococcus pyogenes
>6.8
-
Listeria monocytogenes
>6.3
-
Corynebacterium minutissimum
>6.3
-
Bacillus cereus (includes spores)
3.6
-
Bacillus cereus (vegetative)
>6.0
-
Bifidobacterium adolescentis
>6.5
-
Propionibacterium acnes
>6.7
-
Lactobacillus species
>6.9
-
Clostridium perfringens (vegetative form)
>7.0
-
Spirochete Bacteria
Treponema pallidum (syphilis)
≥6.8 to ≤7.0
>5.9
Borrelia burgdorferi (Lyme disease)
>6.8
>10.6

* “>” refers to inactivation below the limit of detection of the assay
** intracellular
“-” means not tested


Previous PagePlatelet Technical Data Sheet Page 4 of 7Next Page